Medicine

Thyroid

Thyroid news, research, studies, and rapid health briefings. Visit Viral Vitalism for plain-language context, evidence boundaries, and related signals.

1 published article1 rapid briefBuilding this topic

NutritionEmerging evidenceWeight Loss

Calories Are the Accounting System, Not the Whole Metabolic Story

Weight loss requires an energy deficit, but calories alone do not explain appetite, metabolism, food environment, hormones, lean mass, sleep, medications, or long-term maintenance.

VV Signal Score

Strong signal

Sources: 13
Studies: 10
Claims: 8

Biggest Loser metabolic adaptationDIETFITSEndocrine Society obesity pathogenesis

15 min readRead->

News cycle

Rapid Briefs

View all ->

Thyroid Eye DiseaseConfirmed

FDA Approved Lumvoa for Thyroid Eye Disease

Viridian's Lumvoa gives thyroid eye disease patients another FDA-approved option, but the approval should not be framed as a cure or as proof it beats Tepezza.

Why now

The FDA decision changes the treatment-option landscape for thyroid eye disease and gives patients another approved drug to discuss with specialists.

Overclaim risk: medium
Primary source: Trade news
Published: Jun 30, 2026

Research map

View related studies

Research records connected to this topic through topic tags, source records, and timeline events.

Tier 3Clinical guidancetopic context

ATA thyroid and weight

Thyroid and Weight

Clinical guidance from 2026 in American Thyroid Association, translated into key findings, limitations, and consumer relevance.

Why this appears: Shown as discovery context only because no accepted page-level relationship metadata was supplied.

American Thyroid Association / 2026->

Useful source library entries

American Thyroid Association: Thyroid and Weight Reuters: US FDA greenlights Viridian's thyroid eye disease drug